Comparison of HPV DNA Screening using menstrual blood collected in sanitary pads versus cervical swabs in women with both single and multiple sexual partners
DOI:
https://doi.org/10.56294/saludcyt20241091Keywords:
Menstrual Blood, HPV Screening., Single Partner, Multipartner SexualAbstract
Introduction: oersistent high-risk HPV infection is the main cause of cervical cancer. Sexually active women are at risk of HPV infection, especially if they have multiple sexual partners. To detect HPV, the HPV DNA test can be conducted using menstrual blood samples as an alternative to cervical cancer screening.
Objective: this study aims to analyze the comparison of results between HPV DNA screening with menstrual blood in sanitary pads and cervical swabs in women with single and multi-partner sexual.
Method: this study was an analytical observational study with a cross-sectional design. The sample used was 44 women (21 single partners and 23 multiple sexual partner) aged >18 years, sexually active, experiencing regular menstruation. Menstrual blood samples in sanitary pads and cervical swabs were examined PCR method. Statistical tests used Mann Whitney with a significance level of p≤0,05, diagnostic test and ROC description.
Results: HPV DNA was found in 47,6 % (10/21) in menstrual blood and 47,8 % (11/21) in cervical swabs with a significance value of p=1,000 in women with single sexual partners. HPV DNA was detected in 82,6 % (19/23) in menstrual blood and 87 % (20/23) in cervical swabs with a significance value of p=1,000 in women with multiple sexual partners. Menstrual blood in sanitary pads has a sensitivity value of 90,32 %, specificity 92,31 %, positive predictive value 96,5 %, negative predictive value 80 % and accuracy of 91,32 % to detect HPV DNA
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
2. Tjokroprawiro BA, Novitasari K, Saraswati W, Yuliati I, Ulhaq RA, Sulistya HA. The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia. Gynecol Oncol Reports. 2024;51(January):101325.
3. Kemenkes RI. Profil Kesehatan Indonesia 2021. Pusdatin.Kemenkes.Go.Id. 2022. Kementrian Kesehatan Republik Indonesia.
4. Rembet MC, Nadjib M. Implementation of Cervical Cancer Early Detection Program with IV A Test Method in Cilegon City in 2022. Int J Soc Serv Res. 2023;3(7):1811–20.
5. Robbers GML, Bennett LR, Spagnoletti BRM, Wilopo SA. Facilitators and barriers for the delivery and uptake of cervical cancer screening in Indonesia: a scoping review. Glob Health Action. 2021;14(1):1–15.
6. Saldaña-Rodríguez P, Bahena-Román M, Delgado-Romero K, Madrid-Marina V, Torres-Poveda K. Prevalence and Risk Factors for High-Risk Human Papillomavirus Infection and Cervical Disorders: Baseline Findings From an Human Papillomavirus Cohort Study. Cancer Control. 2023;30:1–21.
7. Mekuria M, Edosa K, Endashaw M, Bala ET, Chaka EE, Deriba BS, et al. Prevalence of Cervical Cancer and Associated Factors Among Women Attended Cervical Cancer Screening Center at Gahandi Memorial Hospital, Ethiopia. Cancer Inform. 2021;20:1–6.
8. Agustiansyah P, Rizal Sanif, Siti Nurmaini, Irfannuddin, Legiran. Epidemiology and Risk Factors for Cervical Cancer. Biosci Med J Biomed Transl Res. 2021;5(7):624–31.
9. Ho FD V., Arevalo MVPN, de Claro PTS, Jacomina LE, Germar MJ V., Dee EC, et al. Breast and cervical cancer screening in the Philippines: Challenges and steps forward. Prev Med Reports. 2022;29(July):101936.
10. Chakravarti P, Maheshwari A, Tahlan S, Kadam P, Bagal S, Gore S, et al. Diagnostic accuracy of menstrual blood for human papillomavirus detection in cervical cancer screening: a systematic review. Ecancermedicalscience. 2022;16:1–13.
11. Arrogante O. Sampling techniques and sample size calculation: How and how many participants should I select for my research? Técnicas de muestreo y cálculo del tamaño muestral: Cómo y cuántos participantes debo seleccionar para mi investigación. Enfermería Intensiva [Internet]. 2022;33:44–7. Available from: www.elsevier.es/ei
12. Chongcharoen P, Choobun T, Khanuengkitkong S. Female sexual function index for screening of female sexual dysfunction using DSM-5-TR criteria in Thai women: A prospective cross-sectional diagnostic study. PLoS One. 2024;19(2 February):1–13.
13. Ergin M, Koskan Ö. Comparison of Student – t, Welch s t, and Mann – Whitney U Tests in Terms of Type I Error Rate and Test Power. Selcuk J Agric Food Sci. 2023;8(August):1–10.
14. Zhang J, Tian X, Chen Y, Huang S, Cui Z, Tian R, et al. Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection with Capture Sequencing. JAMA Netw Open. 2021;4(12):1–10.
15. Farahmand M, Moghoofei M, Dorost A, Abbasi S, Monavari SH, Kiani SJ, et al. Prevalence and genotype distribution of genital human papillomavirus infection in female sex workers in the world: A systematic review and meta-analysis. BMC Public Health. 2020;20(1):1–14.
16. Wong JPH, Vahabi M, Miholjcic J, Tan V, Owino M, Li ATW, et al. Knowledge of HPV/cervical cancer and acceptability of HPV self-sampling among women living with HIV: A scoping review. Curr Oncol. 2018;25(1):e73–82.
17. Kangethe JM, Gichuhi S, Odari E, Pintye J, Mutai K, Abdullahi L, et al. Confronting the human papillomavirus–HIV intersection: Cervical cytology implications for Kenyan women living with HIV. South Afr J HIV Med. 2023;24(1):1–12.
18. Fleider LA, de los Ángeles Tinnirello M, Cherey FG, Garcím a M a. G, Cardinal LH, Kamermann FG, et al. High sensitivity and specificity rates of cobas® HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting. PLoS One. 2023;18(2 February):1–9.
19. Rahul Ganavadiya CSB, , Suma S2 , Pallavi Singh3 RG, Poonam Tomar Rana SJD. Effectiveness of two psychological intervention techniques Article for de‑addiction among patients with addiction to tobacco and alcohol – A double‑blind randomized control trial Rahul Ganavadiya, Chandra Shekar BR1 , Suma S2 , Pallavi Singh3 , Ruchika Gu. Indian J Cancer. 2018;55(1):382–9.
20. Budukh A, Palayekar V, Maheshwari A, Deodhar K, Purwar P, Bagal S, et al. Menstrual pad, a cervical cancer screening tool, a population-based study in rural India. Eur J Cancer Prev. 2018;27(6):548–52.
21. Wang Y, Thakur R, Shen Q, He Y, Chen C. Influences of vaginal microbiota on human papillomavirus infection and host immune regulation: What we have learned? Decod Infect Transm. 2023;1(May):100002.
22. Naseri S, Young S, Cruz G, Blumenthal PD. Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood. Obstet Gynecol. 2022;140(3):470–6.
23. Wong SCC, Au TCC, Chan SCS, Chan CML, Lam MYY, Zee BCY, et al. Human papillomavirus DNA detection in menstrual blood from patients with cervical intraepithelial neoplasia and condyloma acuminatum. J Clin Microbiol. 2018;48(3):709–13.
24. Sang K, Remnant J, Calvard T, Myhill K. Blood work: Managing menstruation, menopause and gynaecological health conditions in the workplace. Int J Environ Res Public Health. 2021;18(4):1–16.
25. Tsang H fung, Cheung Y shing, Yu C shing A, Chan C sum S, Wong C bun T, Yim K yuen A, et al. Menstrual Blood as a Diagnostic Specimen for Human Papillomavirus Genotyping and Genital Tract Infection Using Next-Generation Sequencing as a Novel Diagnostic Tool. Diagnostics. 2024;14(686):1–12.
26. Lee N, Cho HY, Jeon KJ, Kim K, Lee JR. J of Obstet and Gynaecol - 2015 - Lee - Detection of high‐risk human papillomavirus using menstrual blood in women with.pdf. Obstet Gynaecol Res. 2016;42(3):319–24.
27. Khayargoli P, Niyibizi J, Audibert F. Association between Human Papillomavirus 16 Viral Load in Pregnancy and Preterm Birth. Viruses MDPI. 2024;16(298):1–13.
28. Warashinta D, Astari A, Merdikawati A. Analysis of the Use of Menstrual Pad, Tampons, and Menstrual Cup During Menarche. J Community Heal Prev Med. 2021;1(2):24–31.
29. Okodo M, Okayama K, Teruya K, Tanabe K, Ito C, Ishii Y, et al. Effects of Menstrual Cycle on the Accumulation of Human Papillomavirus-Infected Cells Exfoliated from the Cervix That Drift into the Vagina. Microorganisms. 2022;10(693):1–11.
30. Naseri S, Lerma K, Blumenthal PD. Comparative Assessment of Serum Versus Menstrual Blood for Diagnostic Purposes [10C]. Obstet Gynecol. 2019;133(1):34S-34S.
31. Chakhtoura N, Mccarthy SH, Harry J, Smith JS. Vaginal Self-Sampling for HPV Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. Sex Transm Dis. 2016;42(11):655–9.
Published
Issue
Section
License
Copyright (c) 2024 Nurul Avifah Rahman, Pungky Mulawardhana, Puspa Wardhani (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
